On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...